Brenda G. Brumback

Array ( [id] => 1426451 [patent_doc_number] => 06504012 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-01-07 [patent_title] => 'Method for preparing dual virally inactivated immune globulin for intravenous administration' [patent_app_type] => B2 [patent_app_number] => 09/861713 [patent_app_country] => US [patent_app_date] => 2001-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4402 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/504/06504012.pdf [firstpage_image] =>[orig_patent_app_number] => 09861713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6901393 [patent_doc_number] => 20010022976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-20 [patent_title] => 'Immunosuppressive and tumour-suppressive bone marrow factor' [patent_app_type] => new [patent_app_number] => 09/819178 [patent_app_country] => US [patent_app_date] => 2001-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 18703 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20010022976.pdf [firstpage_image] =>[orig_patent_app_number] => 09819178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1534312 [patent_doc_number] => 06489123 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-03 [patent_title] => 'Labelling and selection of molecules' [patent_app_type] => B2 [patent_app_number] => 09/767395 [patent_app_country] => US [patent_app_date] => 2001-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 30786 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489123.pdf [firstpage_image] =>[orig_patent_app_number] => 09767395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7014310 [patent_doc_number] => 20010051332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-13 [patent_title] => 'Bovine viral diarrhea virus serum antigen capture' [patent_app_type] => new [patent_app_number] => 09/728525 [patent_app_country] => US [patent_app_date] => 2000-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4890 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20010051332.pdf [firstpage_image] =>[orig_patent_app_number] => 09728525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6884847 [patent_doc_number] => 20010039008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-08 [patent_title] => 'Anticytomegalovirus monoclonal antibodies and processes for the in vitro diagnosis of infections by human cytomegaloviruses and a protein-kinase inducible by cytomegaloviruses and recognisable by aforesaid monoclonal antibodies' [patent_app_type] => new [patent_app_number] => 09/725195 [patent_app_country] => US [patent_app_date] => 2000-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5374 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20010039008.pdf [firstpage_image] =>[orig_patent_app_number] => 09725195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1030992 [patent_doc_number] => 06878543 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-12 [patent_title] => 'Cultures of GFAP+ nestin+ cells that differentiate to neurons' [patent_app_type] => utility [patent_app_number] => 09/696530 [patent_app_country] => US [patent_app_date] => 2000-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15705 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/878/06878543.pdf [firstpage_image] =>[orig_patent_app_number] => 09696530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1297931 [patent_doc_number] => 06627610 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-30 [patent_title] => 'Method for inhibition of viral morphogenesis' [patent_app_type] => B1 [patent_app_number] => 09/687267 [patent_app_country] => US [patent_app_date] => 2000-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 9 [patent_no_of_words] => 4780 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/627/06627610.pdf [firstpage_image] =>[orig_patent_app_number] => 09687267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 750696 [patent_doc_number] => 07022815 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-04-04 [patent_title] => 'Polypeptide derivatives of parathyroid hormone (PTH)' [patent_app_type] => utility [patent_app_number] => 09/672020 [patent_app_country] => US [patent_app_date] => 2000-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 25 [patent_no_of_words] => 24021 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022815.pdf [firstpage_image] =>[orig_patent_app_number] => 09672020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1317588 [patent_doc_number] => RE038202 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Antibodies specific for a haemostatic protein, their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein' [patent_app_type] => E1 [patent_app_number] => 09/618592 [patent_app_country] => US [patent_app_date] => 2000-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7899 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/038/RE038202.pdf [firstpage_image] =>[orig_patent_app_number] => 09618592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1584031 [patent_doc_number] => 06358512 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Feline infectious peritonitis vaccine' [patent_app_type] => B1 [patent_app_number] => 09/592991 [patent_app_country] => US [patent_app_date] => 2000-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5806 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358512.pdf [firstpage_image] =>[orig_patent_app_number] => 09592991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1387258 [patent_doc_number] => 06552180 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-2 and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/579197 [patent_app_country] => US [patent_app_date] => 2000-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 20 [patent_no_of_words] => 25504 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/552/06552180.pdf [firstpage_image] =>[orig_patent_app_number] => 09579197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560757 [patent_doc_number] => 06437097 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Mammalian pro-apoptotic Bok genes and their uses' [patent_app_type] => B1 [patent_app_number] => 09/517358 [patent_app_country] => US [patent_app_date] => 2000-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18109 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/437/06437097.pdf [firstpage_image] =>[orig_patent_app_number] => 09517358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1562309 [patent_doc_number] => 06362320 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-26 [patent_title] => 'Process for purifying hepatitis B viral surface antigen comprising pres2 peptide' [patent_app_type] => B1 [patent_app_number] => 09/432300 [patent_app_country] => US [patent_app_date] => 1999-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7258 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 233 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/362/06362320.pdf [firstpage_image] =>[orig_patent_app_number] => 09432300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494980 [patent_doc_number] => 06342588 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Labelling and selection of molecules' [patent_app_type] => B1 [patent_app_number] => 09/375314 [patent_app_country] => US [patent_app_date] => 1999-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 30932 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 312 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342588.pdf [firstpage_image] =>[orig_patent_app_number] => 09375314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4262915 [patent_doc_number] => 06258937 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Hepadnavirus receptor' [patent_app_type] => 1 [patent_app_number] => 9/361707 [patent_app_country] => US [patent_app_date] => 1999-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 55 [patent_no_of_words] => 42393 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258937.pdf [firstpage_image] =>[orig_patent_app_number] => 361707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288733 [patent_doc_number] => 06183742 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-06 [patent_title] => 'Applications of lysozyme dimer' [patent_app_type] => 1 [patent_app_number] => 9/348822 [patent_app_country] => US [patent_app_date] => 1999-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 10745 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/183/06183742.pdf [firstpage_image] =>[orig_patent_app_number] => 348822 [rel_patent_id] =>[rel_patent_doc_number] =>)